OCT 27, 2026 · JOURNAL ARTICLE
An International Study of Pembrolizumab for Drug-Resistant Gestational Trophoblastic Neoplasia
NEJM Evidence
BACKGROUND: Data to guide use of anti-PD1 immunotherapy with pembrolizumab for gestational trophoblastic neoplasia (GTN) that is chemotherapy-resistant or in adjuvant settings are